Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $5.4300 (-2.43%) ($5.2400 - $5.6000) on Mon. Jul. 13, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.56% (three month average) | RSI | 82 | Latest Price | $5.4300(-2.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1.5% a day on average for past five trading days. | Weekly Trend | BCRX advances 12.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) GDX(7%) XLC(7%) XLU(7%) GDXJ(6%) REMX(6%) | Factors Impacting BCRX price | BCRX will decline at least -3.78% in a week (0% probabilities). IGOV(-5%) EWP(-4%) DRIV(-4%) SMH(-3%) UUP(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.78% (StdDev 7.56%) | Hourly BBV | -2.2 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $5.35(1.5%) | 10 Day Moving Average | $5.14(5.64%) | 20 Day Moving Average | $4.7(15.53%) | To recent high | -2.8% | To recent low | 8.3% | Market Cap | $N/A | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |